Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.
The fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization.We incubated 2...
Main Authors: | Sebastian Fischer, Christoph Hirche, Yannick Diehm, Kristo Nuutila, Jurij Kiefer, Emre Gazyakan, Ericka M Bueno, Thomas Kremer, Ulrich Kneser, Bohdan Pomahac |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4883774?pdf=render |
Similar Items
-
Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation
by: Miriam Brazzelli, et al.
Published: (2015-10-01) -
Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
by: Kimitoshi Noto, MD, et al.
Published: (2020-01-01) -
The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren’s contracture management: A meta-analysis
by: Tokai B Cooper, et al.
Published: (2020-06-01) -
Magnetic resonance imaging of diffusion characteristics following collagenase clostridium histolyticum injection in Dupuytren’s contracture
by: Hiroko Iwakawa, et al.
Published: (2021-09-01) -
Treatment of Dupuytren’s contracture with collagenase clostridium histolyticum under clinical practice conditions: ReDUCTo study
by: Haerle, Max, et al.
Published: (2015-08-01)